SCHEMBL382217

SCHEMBL382217

NC(=O)NCNC(CS)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
PTGS2 P35354 1/20 0.44
THPO P40225 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ACE P12821 1/20 0.40
FOLH1 Q04609 1/20 0.38
PTGS1 P23219 2/20 0.37
SLC7A11 Q9UPY5 1/20 0.37
TGFBR1 P36897 1/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
ENPEP Q07075 3/20 0.33
GSTK1 Q9Y2Q3 1/20 0.33
BCAT2 O15382 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679687 0.83 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL205287 0.83 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL205286 0.83 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL10977192 0.83 KDM4E (0.54) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL467823 0.80 KDM4E (0.59) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL210386 0.80 KDM4E (0.59) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL467821 0.80 KDM4E (0.59) KDM4EMAPTTHRBALOX15NFKB1
Hydrochloric Acid SCHEMBL11206313 0.78 KDM4E (0.57) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL3937605 0.75 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL3937603 0.75 KDM4E (0.47) KDM4EMAPTTHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391826-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASES Sanford Burnham Prebys Medical Discovery Institute 2023-12-07 US claimed
WO-2022056473-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASES Sanford Burnham Prebys Medical Discovery Institute (US) 2022-03-17 WO claimed
US-20240219396-A1 METHODS OF PREPARING SAMPLES FOR PROTEOMIC ANALYSIS STRECK LLC 2024-07-04 US disclosed
EP-4384619-A2 RIBOSOMAL RNA (RRNA) VARIANTS POSSESSING ENHANCED PROTEIN PRODUCTION CAPABILITIES The Broad Institute, Inc. (US) 2024-06-19 EP disclosed
US-20240142444-A1 DIAGNOSTIC METHOD FOR INFECTIOUS DISEASES GEORGE MASON UNIVERSITY 2024-05-02 US disclosed
WO-2024091897-A2 DE NOVO DESIGNED MODULAR PEPTIDE BINDING PROTEINS BY SUPERHELICAL MATCHING UNIVERSITY OF WASHINGTON (US) 2024-05-02 WO disclosed
US-11965881-B2 Nanosensors and methods for detection of biological markers KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2024-04-23 US disclosed
US-20240123059-A1 Kaposi's Sarcoma Associated Herpesvirus Vaccine and Methods of Making and Using Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-04-18 US disclosed
US-20240125800-A1 NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2024-04-18 US disclosed
EP-3494966-B1 IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION ONCOUR PHARMA INC (US) 2024-04-03 EP disclosed
EP-3042190-B1 HIGH SENSITIVITY ELECTROSPRAY INTERFACE UNIV NOTRE DAME DU LAC (US) 2024-04-03 EP disclosed
EP-1317765-A2 AUTOMATED IDENTIFICATION OF PEPTIDES Oxford GlycoSciences (UK) Limited (GB) 2003-06-11 EP disclosed
US-20020102610-A1 Automated identification of peptides OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2002-08-01 US disclosed
WO-2002021139-A2 AUTOMATED IDENTIFICATION OF PEPTIDES OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2002-03-14 WO disclosed
US-5905185-A EXPERIMENTAL EVIDENCE INDICATES THAT PROTEIN C MAY BE CLINICALLY USEFUL IN THE TREATMENT OF THROMBOSIS. IN ADDITION, EXOGENOUS ACTIVATED PROTEIN C HAS BEEN SHOWN TO PREVENT THE COAGULOPATHIC AND LETHAL EFFECTS OF GRAM NEGATIVE SEPTICEMIA. PPL THERAPEUTICS (GB) 1999-05-18 US disclosed
EP-0874898-A1 PROTEIN C PRODUCTION IN TRANSGENIC ANIMALS ZymoGenetics, Inc. (US) 1998-11-04 EP disclosed
WO-1997020043-A1 PROTEIN C PRODUCTION IN TRANSGENIC ANIMALS ZYMOGENETICS, INC. (US) 1997-06-05 WO disclosed
US-5079230-A Reducing small-loop disulfide bonds and blocking the resulting sulfhydryl groups, storage stability PITMAN-MOORE, INC. (US) 1992-01-07 US disclosed
EP-0433395-A1 STABLE BIOACTIVE SOMATOTROPINS MALLINCKRODT VETERINARY, INC. (US) 1991-06-26 EP disclosed
WO-1990002758-A1 STABLE BIOACTIVE SOMATOTROPINS PITMAN-MOORE, INC. (US) 1990-03-22 WO disclosed